MNOV Stock Price History and Quote Analysis: Insights for Investors
MediciNova, Inc.
Stock Price Today
MediciNova, Inc. (MNOV) stock declined over -9.05%, trading at $1.91 on NASDAQ, down from the previous close of $2.10. The stock opened at $2.04, fluctuating between $1.82 and $2.10 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
Company Information
| Employees | 13 |
| Beta | 0.726 |
| Sales or Revenue | $1.00M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
MediciNova, Inc. (NASDAQ: MNOV) stock price is $1.91 in the last trading session. During the trading session, MNOV stock reached the peak price of $2.10 while $1.82 was the lowest point it dropped to. The percentage change in MNOV stock occurred in the recent session was -9.05% while the dollar amount for the price change in MNOV stock was -$0.19.
The NASDAQ listed MNOV is part of Biotechnology industry that operates in the broader Healthcare sector. MediciNova, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. John O'Neil CPA
Controller
Mr. Jason J. Kruger CPA
Chief Financial Officer & Principal Financial Officer
Dr. Yuichi Iwaki M.D., Ph.D.
Co-Founder, Pres, Chief Executive Officer & Executive Director
Dr. Kazuko Matsuda M.D., M.P.H., MPH, Ph.D.
Chief Medical Officer & Director
Dr. David H. Crean M.B.A., Ph.D.
Chief Bus. Officer
MNOV's closing price is 70.54% higher than its 52-week low of $1.12 where as its distance from 52-week high of $2.38 is -19.75%.
Number of MNOV employees currently stands at 13.
Official Website of MNOV is: https://www.medicinova.com
MNOV could be contacted at phone 858 373 1500 and can also be accessed through its website. MNOV operates from 4275 Executive Square, La Jolla, CA 92037, United States.
MNOV stock volume for the day was 120.25K shares. The average number of MNOV shares traded daily for last 3 months was 39.16K.
The market value of MNOV currently stands at $93.68M with its latest stock price at $1.91 and 49.05M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com